AA
FLNA

Ancora Advisors’s Filana Therapeutics FLNA Stock Holding History

Ancora Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-500
Closed -$14.7K – 1870
2024
Q3 		$14.7K Hold
500
– – ﹤0.01% 1256
2024
Q2 		$6.17K Hold
500
– – ﹤0.01% 1402
2024
Q1 		$10.1K Hold
500
– – ﹤0.01% 1318
2023
Q4 		$11.3K Hold
500
– – ﹤0.01% 1266
2023
Q3 		$8.32K Hold
500
– – ﹤0.01% 1318
2023
Q2 		$12.3K Hold
500
– – ﹤0.01% 1239
2023
Q1 		$12.1K Hold
500
– – ﹤0.01% 1233
2022
Q4 		$15K Hold
500
– – ﹤0.01% 1253
2022
Q3 		$21K Buy
+500
New +$13.5K ﹤0.01% 1322
2022
Q2 		– Sell
-500
Closed -$19K – 2319
2022
Q1 		$19K Hold
500
– – ﹤0.01% 1567
2021
Q4 		$22K Hold
500
– – ﹤0.01% 1558
2021
Q3 		$31K Buy
+500
New +$41.7K ﹤0.01% 1340
2018
Q4 		– Sell
-70
Closed – – 1078
2018
Q3 		$0 Buy
+70
New +$106 ﹤0.01% 1350

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Ancora Advisors's FLNA Position: Q4 2024 in Review

Ancora Advisors sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 500 shares — an estimated $14.7K sold.

Ancora Advisors first reported a position in FLNA in Q3 2018 and held it in 13 quarters. The position peaked at $31K in Q3 2021. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Ancora Advisors reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Ancora Advisors sold 500 Filana Therapeutics shares in Q4 2024, an estimated $14.7K.
  • Ancora Advisors first reported a position in Filana Therapeutics in Q3 2018 and held it in 13 quarters.
  • Ancora Advisors's Filana Therapeutics position peaked at $31K in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Ancora Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.